Doripenem pharmacokinetics in critically ill patients receiving continuous hemodiafiltration (CHDF)

Yakugaku Zasshi

Volumn 130, Issue 1, 2010, Pages 87-94

  Hidaka, Seigo ^a   Goto, Koji ^a   Hagiwara, Satoshi ^a   Iwasaka, Hideo ^a   Noguchi, Takayuki ^a  

^a Faculty of Medicine   (Japan)

Author keywords

Acute renal failure; Antibiotic; Hemodiafiltration; Pharmacology

Indexed keywords

DORIPENEM;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SAFETY; FEMALE; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; MALE;

AGED; AGED, 80 AND OVER; CARBAPENEMS; CRITICAL ILLNESS; FEMALE; HALF-LIFE; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 74849108289     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.130.87     Document Type: Article

References (20)

1. Murray P., Hall J., Am. J. Respir. Crit. Care Med., 162, 777-781 (2000).
2. Sadahiro T., Hirasawa H., Oda S., Shiga H., Nakanishi K., Kitamura N., Hirano T., Crit. Care Med., 29, 1386-1392 (2001).
3. Jiang H. L., Xue W. J., Li D. Q., Yin A. P., Xin X., Li C. M., Gao J. L., World J. Gastroenterol., 11, 4815-4821 (2005).
4. Page B., Vieillard-Baron A., Chergui K., Peyrouset O., Rabiller A., Beauchet A., Aegerter P., Jardin F., Crit. Care, 9, R755-R763 (2005).
5. Thalhammer F., Schenk P., Burgmann H., El Menyawi I., Hollenstein U. M., Rosenkranz A. K., Sunder-Plassmann G., Breyer S., Ratheiser K., Antimicrob. Agents Chemother., 42, 2417-2420 (1998).
6. DelDot M. E., Lipman J., Tett S. E., Br. J. Clin. Pharmacol., 58, 259-268 (2004).
7. Hayakawa M., Ito Y., Fujita I., Iseki K., Gando S., ASAIO J., 52, 398-403 (2006).
8. Griffith D. E., Aksamit T., Brown-Elliott B. A., Catanzaro A., Daley C., Gordin F., Holland S. M., Horsburgh K., Huitt G., Iademarco M. F., Iseman M., Olivier K., Ruoss S., von Reyn C. F., Wallace K. J. Jr., Winthrop K., Am. J. Respir. Crit. Care Med., 175, 367-416 (2007).
9. Kishino S., Takekuma Y., Sugawara M., Shimamura T., Furukawa H., Todo S., Miyazaki K., J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 780, 289-294 (2002).
10. Uehara S., Murao W., Seno Y., Andoh E., Monden K., Kariyama K., Tsugawa M., Nakashima M., Kumon H., Jpn. J. Chemother. 53, 130-135 (2005).
11. Bochud P. Y., Bonten M., Marchetti O., Calandra T., Crit. Care Med., 32, S495-512 (2004).
12. Tsuji M., Ishii Y., Ohno A., Miyazaki S., Yamaguchi K., Antimicrob. Agents Chemother., 42, 94-99 (1998).
13. Sakyo S., Tomita H., Tanimoto K., Fujimoto S., Ike Y., J. Antibiot., 59, 220-228 (2006).
14. Horiuchi M., Kimura M., Tokumura M., Hasebe N., Arai T., Abe K., Toxicology, 222, 114 (2006).
15. Keil S., Wiedemann B., Antimicrob. Agents Chemother., 41, 1215-1219 (1997).
16. Nakajima M., Oguma T., Jpn. J. Chemother., 53, S104-123 (2005).
17. Iga T., Medical Practice, 19, 244-248 (2002).
18. Cotterill S., J. Antimicrob. Chemother., 36, 773-780 (1995).
19. Ronco C., Bellomo K., Homel P., Brendolan A., Dan M., Piccinni P., La Greca G., Lancet, 356, 26-30 (2000).
20. Hidaka S., Goto K., Matsumoto S., Oyama T., Yamamoto S., Yasuda N., Hagiwara S., Shingu C., Iwasaka H., Noguchi T., Rinsho to Biseibutsu, 35, 199-203 (2008).